A dose-escalation phase II clinical trial of infusional mitomycin C for 7 days in patients with advanced measurable colorectal cancer refractory or resistant to 5-fluorouracil.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples